Argireline (Acetyl Hexapeptide-8) vs Matrixyl (Palmitoyl Pentapeptide)

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Argireline (Acetyl Hexapeptide-8) and Matrixyl (Palmitoyl Pentapeptide) are both cosmetic & skin peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Argireline (Acetyl Hexapeptide-8) and Matrixyl (Palmitoyl Pentapeptide) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Argireline (Acetyl Hexapeptide-8)Matrixyl (Palmitoyl Pentapeptide)
CategoryCosmetic & SkinCosmetic & Skin
Regulatory status (US)Research use onlyResearch use only
Typical dosageTopical 5-10%Topical application
Frequencydailydaily
Reported benefitsWrinkle reduction, expression line smoothingWrinkle reduction, skin firmness, collagen stimulation, improved skin texture
Reported side effectsVery safe for topical useVery safe for topical use. Rare: mild irritation

Key differences

Primary use. Argireline (Acetyl Hexapeptide-8) is categorised under Cosmetic & Skin, while Matrixyl (Palmitoyl Pentapeptide) falls under Cosmetic & Skin. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Argireline (Acetyl Hexapeptide-8): not FDA-approved; treated as a research compound. Matrixyl (Palmitoyl Pentapeptide): not FDA-approved; treated as a research compound.

Dosing. Argireline (Acetyl Hexapeptide-8) is typically dosed at Topical 5-10% (daily). Matrixyl (Palmitoyl Pentapeptide) is typically dosed at Topical application (daily).

Can you stack them?

Some protocols combine peptides, but stacking Argireline (Acetyl Hexapeptide-8) and Matrixyl (Palmitoyl Pentapeptide) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Argireline (Acetyl Hexapeptide-8) and Matrixyl (Palmitoyl Pentapeptide)?
Argireline (Acetyl Hexapeptide-8) and Matrixyl (Palmitoyl Pentapeptide) are both cosmetic & skin peptides, but they differ in mechanism, dosing, and regulatory status. Argireline (Acetyl Hexapeptide-8) is not FDA-approved; generally classified as a research compound, whereas Matrixyl (Palmitoyl Pentapeptide) is not FDA-approved; generally classified as a research compound.
What is Argireline (Acetyl Hexapeptide-8) used for?
Botox-like peptide.
What is Matrixyl (Palmitoyl Pentapeptide) used for?
Anti-aging skincare.
Can you take Argireline (Acetyl Hexapeptide-8) and Matrixyl (Palmitoyl Pentapeptide) together?
Some users combine peptides within a single protocol, but stacking Argireline (Acetyl Hexapeptide-8) and Matrixyl (Palmitoyl Pentapeptide) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Argireline (Acetyl Hexapeptide-8) or Matrixyl (Palmitoyl Pentapeptide) FDA-approved?
Argireline (Acetyl Hexapeptide-8) is not FDA-approved; generally classified as a research compound. Matrixyl (Palmitoyl Pentapeptide) is not FDA-approved; generally classified as a research compound.

Read the full articles

More Cosmetic & Skin comparisons

← All peptide comparisons